Vistagen Therapeutics, Inc.
Balance Sheet
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $10.4M | $2.9M | $428.5K | $70.0K | — | $638.1K | $81.0K | $139.3K |
| Accounts Receivable | — | — | — | — | — | — | $106.2K | $42.2K |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $11.0M | $3.4M | $855.3K | $105.7K | $40.5K | $671.8K | $238.1K | $204.8K |
| Property, Plant & Equipment | $207.4K | $286.5K | $87.6K | $117.1K | $176.3K | $180.7K | $74.5K | $87.7K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $11.3M | $3.7M | $989.8K | $269.7K | $263.7K | $881.5K | $341.6K | $323.6K |
| Liabilities | ||||||||
| Accounts Payable | $1.2M | $867.3K | $936.0K | $2.3M | $2.4M | $1.4M | $1.8M | $1.8M |
| Total Current Liabilities | $1.5M | $1.4M | $1.8M | $17.4M | $5.2M | $2.4M | $3.2M | $10.8M |
| Long-Term Debt | — | — | $58.8K | $1.5M | $2.1M | — | — | — |
| Total Liabilities | $4.4M | $3.1M | $4.0M | $20.8M | $13.1M | $13.4M | $6.0M | $18.7M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-156.5M | $-142.0M | $-131.7M | $-84.5M | $-70.6M | $-67.7M | $-54.8M | $-42.6M |
| Total Stockholders' Equity | $6.9M | $615.8K | $-3.0M | $-20.5M | $-12.8M | $-12.6M | $-5.7M | $-32.9M |